PAVmed Inc (PAVM)
1.79
-0.09
(-4.79%)
USD |
NASDAQ |
May 17, 16:00
1.79
0.00 (0.00%)
After-Hours: 20:00
PAVmed Research and Development Expense (Annual): 14.28M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.28M |
| December 31, 2022 | 25.34M |
| December 31, 2021 | 19.85M |
| December 31, 2020 | 10.96M |
| December 31, 2019 | 6.63M |
| Date | Value |
|---|---|
| December 31, 2018 | 4.253M |
| December 31, 2017 | 2.622M |
| December 31, 2016 | 1.720M |
| December 31, 2015 | 0.4893M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
6.63M
Minimum
2019
25.34M
Maximum
2022
15.41M
Average
14.28M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Cutera Inc | 21.41M |
| Dynatronics Corp | -- |
| Stereotaxis Inc | 10.27M |
| Electromed Inc | 0.916M |
| Myomo Inc | 2.636M |